• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH HEPARIN LOCK FLUSH SYRINGE; FLUSH SYRINGE- HEPARIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL (BD WEST) MEDICAL SURGICAL BD POSIFLUSH HEPARIN LOCK FLUSH SYRINGE; FLUSH SYRINGE- HEPARIN Back to Search Results
Catalog Number 306424
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Fever (1858); Nausea (1970); Vomiting (2144); Alteration In Body Temperature (2682)
Event Date 05/10/2018
Event Type  Injury  
Manufacturer Narrative
The date received by manufacturer has been used for this field.Investigation summary: no samples were available to bd for evaluation.Therefore, a quality engineer was unable to perform a thorough investigation regarding the reported reaction.However, an engineer was able to review the inspections performed at the manufacturing facility and found no rejections.Bd has controls in place to reduce any chance of contamination.There are weekly bioburden tests, an overkill sterilization process, biweekly environmental testing within the filling area, the solution is filtered twice before the syringes are filled, once when transferring from the hold tank and again at the fill station, endotoxin testing performed on each batch and the pure steam system, continuous online monitoring of the wfi water quality and each sterilizer is thoroughly validated before being used for posiflush sterilization.However, without a sample to investigate bd was unable to determine a possible root cause for this issue.A device history review was performed on the reported lot and it revealed zero documented issue found during this production run.Complaints received for this product and condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business regularly reviews the collected data for identification of emerging trends.Investigation conclusion: dhr/bhr review there was no documentation of issues for the complaint of batch # 732597n during this production run.Investigation comments: all our inspections performed while manufacturing this batch # were accepted; no rejections were documented.Controls in place, at the manufacturing site: - bioburden tested on a weekly basis.- an overkill sterilization process is used.- environmental testing within the filling area is done on a biweekly basis.- the sterilization process is challenged and re-qualified annually.- the solution is filtered twice before it is filled in syringes (note: once when transferring to the hold tank and again at the fill machine).- endotoxin testing is performed on each batch.- fill room operators are trained and qualified on gowning for the fill room environment on an annual basis.- weekly bioburden testing on the components used to assemble the syringes.- continuous online monitoring of the wfi water quality (note: this is for toc and conductivity, not microbial - weekly bioburden and endotoxin testing of the usp purified water and wfi systems.- weekly endotoxin testing of the pure steam system.- each sterilizer is thoroughly validated before used for posiflush sterilization.Product within specification? yes / no.Root cause description: root cause could not be determined.There were no qns issued during the production of this batch # listed in the complaint.All inspections were accepted during the production of this batch.There was no issue documented.Root cause is unknown.Rationale: capa not required for this event.
 
Event Description
It was reported that the customer experienced nausea/ vomiting, clammy pale chills and low fever while using the bd posiflush heparin lock flush syringe.Found during use.The customer consulted with his physician dr (b)(6) and was given nausea medication and instructed to go to the emergency room if symptoms get worse.
 
Manufacturer Narrative
Additional information received from customer; "i am happy to inform that my husband (b)(6) is now an outpatient at home and is doing well.The heparin i used to flush his pic-line seems to have had no ill effects on (b)(6).".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD POSIFLUSH HEPARIN LOCK FLUSH SYRINGE
Type of Device
FLUSH SYRINGE- HEPARIN
Manufacturer (Section D)
BD MEDICAL (BD WEST) MEDICAL SURGICAL
1852 10th avenue
columbus NE 68601
MDR Report Key7557848
MDR Text Key109695433
Report Number1911916-2018-00246
Device Sequence Number1
Product Code NZW
UDI-Device Identifier00382903064243
UDI-Public00382903064243
Combination Product (y/n)N
PMA/PMN Number
K090680
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Patient Family Member or Friend
Device Expiration Date11/30/2019
Device Catalogue Number306424
Device Lot Number732597N
Was Device Available for Evaluation? No
Date Manufacturer Received05/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-